EN
HI
Summary
As of 10 Nov, 2026, Eiko Lifesciences stock price is ₹49.87. During the trading session, the stock has moved between an intraday low of ₹47.65 and an intraday high of ₹52.92. Over the last 52 weeks, Eiko Lifesciences has traded between ₹43.00 and ₹59.00.
The stock has recorded a trading volume of 18,401 shares,. Its Average Traded Price (ATP) is ₹49.70, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹49.87.
Eiko Lifesciences has an upper circuit limit of ₹62.31 and a lower circuit limit of ₹41.55. The total value traded stands at ₹9.15 L, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Eiko Lifesciences also offers a dividend yield of 0%.
Eiko Lifesciences Share Price Chart
Eiko Lifesciences Share Key Metrics
Volume
18401.00
Market Cap
73.80 CR
LTQ@LTP
1@49.87
ATP
49.7
Var Margin
25 %
Circuit Range
41.55-62.31
Delivery %
100 %
Value
9.15 L
ASM/GSM
No
Market Lot
1
Eiko Lifesciences Fundamentals
P/E Ratio
14.33
P/B Ratio
1.1
Div. Yield
0
Sector P/E
52.02
Sector P/B
2.57
Sec. Div. Yield
0.62
Eiko Lifesciences Resistance and Support
Pivot 51.93
Resistance
First Resistance
52.01
Second Resistance
52.08
Third Resistance
52.16
Support
First Support
51.86
Second Support
51.78
Third Support
51.71
Eiko Lifesciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Nov 09 2026 | 50.02 | 49.87 | -3.97% | 52.92 | 47.65 |
| Sun Nov 08 2026 | 52 | 51.93 | 2.47% | 52 | 51.84 |
| Fri Nov 06 2026 | 52 | 50.68 | -1.46% | 52.49 | 50 |
Eiko Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-05 | Quarterly Results |
| 2026-08-12 | Quarterly Results |
| 2026-05-26 | Audited Results |
| 2026-01-29 | Quarterly Results |
| 2025-12-11 | Others |
| 2025-10-31 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-14 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-25 | Rights issue of Equity Shares |
| 2024-10-19 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Eiko Lifesciences News
Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Restructuring
Eiko Lifesciences' wholly-owned subsidiary, Eiko Scientific Solutions LLP, is forming a 50:50 joint venture with Oval Projects Engineering. The new entity, Oval Eiko Resources Pvt Ltd, will focus on compressed bio gas production and distribution.
Nov 05 2026 21:31:01
Eiko Lifesciences Ltd - 540204 - Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. On Thursday, 05Th November, 2026.
EIKO Lifesciences reported Q2 FY27 cons. revenue of ₹17.72 crores (up 51.8% YoY) and net profit of ₹1.56 crores (up 21.7% YoY). Additionally, its wholly-owned subsidiary, Eiko Scientific Solutions LLP, will form a 50-50 joint venture named Oval Eiko Resources Pvt Ltd with Oval Projects Engineering Ltd to enter compressed bio gas production.
Nov 05 2026 16:57:44
Read More
Eiko Lifesciences Management
| Name | Position |
|---|---|
| Chintan Doshi | Company Secretary & Compliance Officer |
| Laxmikant Ramprasad Kabra | Chairman |
Eiko Lifesciences Similar Stocks
Aik Pipes & Polymers Ltd.
30.99
0.61 (2.01%)
Nagarjuna Fertilizers and Chemicals Ltd.
1.28
-0.06 (4.48%)
TPI India Ltd.
14.54
0.25 (1.75%)
Kisaan Parivar Industries Ltd.
10.80
0.17 (1.60%)
Technichem Organics Ltd.
42.00
0.77 (1.87%)
Amtech Esters Ltd.
84.85
1.35 (1.62%)
Hardcastle & Waud Manufacturing Company Ltd.
839.50
-4.40 (0.52%)
APT Packaging Ltd.
67.00
2.84 (4.43%)
Eiko Lifesciences FAQs
The Buying Price of Eiko Lifesciences share is 49.87 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Eiko Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Eiko Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Eiko Lifesciences shares is 14.33. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Eiko Lifesciences shares is 1.1. Useful to assess the stock's value relative to its book value.
To assess Eiko Lifesciences’s valuation compare Sector P/E, P/B which are 52.02 & 2.57 with sector averages, along with growth rates and financial metrics.
The Market Cap of Eiko Lifesciences is 73.80 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Eiko Lifesciences share price is 59.00 & 43.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Eiko Lifesciences belongs to the Chemicals sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in EIKO
